Navigation Links
Oncothyreon reports full year and fourth quarter 2008 financial results
Date:3/9/2009

--------- --------- --------- --------- Income (loss) per share - Diluted.................... $ 1.06 $ (0.26) $ 0.36 $ (1.04) --------- --------- --------- --------- Shares used to compute basic income (loss) per share.... 19,492 19,486 19,491 19,486 --------- --------- --------- --------- Shares used to compute diluted income (loss) per share...................... 19,572 19,486 19,572 19,486 --------- --------- --------- --------- Oncothyreon Inc. Consolidated Balance Sheet Data (in thousands of U.S. dollars) (unaudited) December 31, December 31, 2008 2007 Cash, cash equivalents and short term investments................................... $ 19,166 $ 24,186 Total assets................................... 24,971 36,218 Total long-term liabilities.................... 393 12,526 Stockholders' equity........................... 20,717 12,019 Common shares outstanding...................... 19,492 19,486


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
2. Oncothyreon to present at BIO CEO & Investor Conference 2009
3. Oncothyreon reports third quarter 2008 financial results
4. Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
5. Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
6. Oncothyreon to present at BIO Investor Forum 2008
7. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
8. Oncothyreon announces prioritization plan for development programs
9. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
10. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
11. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015   GenoSpace ... for the interpretation and analysis of genomic and ... Fischer has joined the company as Vice ... - http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace ... to integrate, interpret, analyze and explore complex sets ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on the ... state of the global Propanol market with a focus on the Chinese situation. Major ... Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... NVAX ) a clinical-stage vaccine company, announced today ... be presenting at,the Piper Jaffray 20th Annual Healthcare Conference ... York. Dr. Singhvi will provide an overview of the,company,s ... live,presentation can be accessed via the Company website at ...
... FHC ), which manufactures and markets the FC Female ... year ended,September 30, 2008. , ... revenues increased 52%,to $7.8 million, compared with $5.2 million in ... attributable to common stockholders of,$2.3 million, or $0.08 per diluted ...
... Regado Biosciences, Inc.,announced today David J. Mazzo, Ph.D., President ... Piper Jaffray Health Care Conference in New,York, NY, on ... Mazzo will discuss the Company,s development pipeline, in addition ... About Regado Biosciences , ...
Cached Biology Technology:The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 2The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 3The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 4The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 5The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 6The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 7The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 8
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2
... SARS. Ebola. Bird Flu. Swine Flu. Rabies. These are ... one animal species into another and now infect humans. ... and scientists are working to determine what drives it. ... Tennessee, Knoxville, and department head in Ecology and Evolutionary ...
... (August 5, 2010) With global warming and climate ... reassuring to know that some creatures might cope by ... become less hospitable. Nevertheless, natural relocation of species is ... to Jessica Hellmann, Associate Professor at the University of ...
... , RIVERSIDE, Calif. Tobacco-related disease kills more people ... this problem, the University of California, Riverside has received ... Research Program ( TRDRP ), the most TRDRP grants ... more than $850,000, the grants will fund research on ...
Cached Biology News:UT professor uncovers clues into how viruses jump from hosts 2Butterflies shed light on how some species respond to global warming 2Butterflies shed light on how some species respond to global warming 3UC Riverside receives 6 grants for tobacco-related research 2UC Riverside receives 6 grants for tobacco-related research 3
... Lipid adsorption and clarification reagent; ... the purification of antibodies, proteins, nucleic ... has negligible cross-reactivity, and improves downstream ... a solid-phase, non-ionic adsorbent supplied as ...
A simple, sensitive and reliable method for determining free sulfhydryl content in peptides, protein...
... incubator-shaker, has the smallest footprint of all our ... x 680 mm (W x D) does not ... x 510mm). Available in 25 mm or 50 ... shaking applications requiring controlled speed and temperature ...
Request Info...
Biology Products: